| PMID | Title | Display |
|---|
| 15705896 | Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. |    |
|
| 15723097 | Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. | |
|
| 15776311 | Antiangiogenic, antimicrobial, and cytotoxic potential of sponge-associated bacteria. | |
|
| 15917237 | Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids. | |
|
| 16010427 | Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo. | |
|
| 16055674 | In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue. | |
|
| 16183547 | Dobesilate is an angiogenesis inhibitor. | |
|
| 16317086 | Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. | |
|
| 16495926 | A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours. | |
|
| 16562912 | Total synthesis of ageladine A, an angiogenesis inhibitor from the marine sponge Agelas nakamurai. | |
|
